A drug maker recently doubled the price of chloroquine — but in response to the coronavirus pandemic, it’s cutting it in half

WASHINGTON — A company that makes a medication increasingly touted as a promising coronavirus treatment, known as chloroquine, doubled the drug’s price in late 2019 — but says it has now cut the price in half, to its original level, in response to the pandemic.

Read full article here:

A drug maker recently doubled the price of chloroquine — but in response to the coronavirus pandemic, it’s cutting it in half